Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma-Reference-Cited by-同舟云学术

Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma

Published:2020-04-01 Issue:6 Volume:125 Page:867-875
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Bandini Marco¹^ORCID,Albersen Maarten²,Chipollini Juan³^ORCID,Pederzoli Filippo¹^ORCID,Zhu Yao⁴^ORCID,Ye Ding-Wei⁴,Ornellas Antonio A.⁵,Watkin Nick⁶,Ager Michael⁶,Hakenberg Oliver W.⁷,Heidenreich Axel⁸^ORCID,Raggi Daniele⁹,Catanzaro Mario⁹,Haidl Friederike⁸,Mazzone Elio¹^ORCID,Marandino Laura⁹^ORCID,Briganti Alberto¹,Montorsi Francesco¹,Azizi Mounsif³^ORCID,Spiess Philippe E.³,Necchi Andrea⁷^ORCID

Affiliation:

1. Unit of Urology; Urological Research Institute (URI); IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Milan Italy

2. University Hospitals Leuven; Leuven Belgium

3. Moffitt Cancer Center and Research Institute; Tampa FL USA

4. Fudan University Shanghai Cancer Center; Shanghai China

5. Hospital Mário Kröeff and Brazilian Cancer Institute; Rio de Janeiro Brazil

6. NHS Foundation Trust; St. George’s University Hospitals; London UK

7. University Hospital Rostock; Rostock Germany

8. Universitätsklinikum Köln; Köln Germany

9. Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

Publisher

Wiley